18F-FLT use was more efficient than 18F-FDG in detecting recurrences of high-grade tumors, predicting tumor progression and survival in the follow-up of patients with low- and high-grade gliomas, and 18F-FLT results correlated with the Ki-67 proliferation index (153). This evidence concerns the gene MKI67 and central nervous system cancer.